Astellas Venture Capital: Aim Big



The foundation of every business, other than its product, is money. Earning money these days is as hard as finding one. Apart from a competitive market, a worldwide economic recession is also looming ahead. Venture capitalists have also become more cautious since losing from the dotcom bubble burst. Fortunately there are still venture capitalists willing to take on start up companies.

Science and technology has been a great interest for private equity firms. They prove positive returns in the long run as demands of a fast pace world continue. In the world of biotechnology, Astellas Venture Management is one of the sources of venture capital funds.

The company focuses on start up biotechnology companies. Its investment portfolio includes public companies such as Adherex Technologies, Memory Pharmaceuticals, and EPIX Pharmaceuticals. Private companies under them include F2G Ltd, FASgen, Inc., TaiGen Biotechnology Co., Ltd., and Alba Therapeutics Corporation.

Astellas established a branch in the America in 2006. The headquarters were located at Los Altos, California.

Astellas and biotech

Most venture capitalists invest in high technology businesses. Most of them prefer companies that apply innovative technology to their product or services. They invest large amounts of capital to start up businesses that have a lot of growth potential in science, research and development.

One of these private equity firms is Astellas Venture Management. Astellas was originally founded in Tokyo Japan. The company was formed after Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. merged. Both of these companies have already been investing in biotechnology companies in Japan before Astellas was formed. Astellas is now managing funds of clients from Yamanouchi and Fujisawa, including new limited partnerships.

The focus of AVM is to find companies that have innovative technology and assist its growth by using its experience and network in the field of biotechnology. They offer investments for companies that have the potential to become leaders in the global market. They prefer emerging companies that are developing pharmaceutical seeds and new drug platforms.

AVM is obviously a big firm. They have a comprehensive resource available to their clients from personnel networks to marketing operations. Apart from investments it also provides companies with scientific and technical proficiency, experience in drug development, marketing knowledge and long-term perspective. This is a big opportunity for those companies who want to have rapid growth and success.

For those companies with a very ambitious management team this will be good partnership for them. AVM caters to no less than large markets that span globally not just locally. Their parent company called Astellas Pharma Inc. is one of the top pharmaceutical companies. This gives them the edge when it comes to experience. They are a cut above the rest when it comes to disease areas such as Immunology and Urology. The form is interested in the fields of Cancer, Pain, Diabetes and metabolic diseases.

Having a pharmaceutical company is both good for entrepreneurs and investors. One of areas that are cannot be touched by recession is health care and medical services. Although being responsible for the well being of many people is a challenge it can also be rewarding.

If you wish to delve in to a more competitive atmosphere and target a large market then you can go AVM, provided that you do have the scientific capabilities to back it up.




Comments

*Name:
*Email:
Website URL:
Title / Subject:
Hide my email
*Comments:
*
 



Menu


My Articles

Pitfalls To Avoid In Applying For A Venture Capital
What Is A Venture Capital Course?
Advantage In New Orleans: Capital For The Underdogs
How To Raise Venture Capital Funding
Venture Capital – Things That You Should Know
What Is Venture Capital Fund?
What The Definition Of Venture Capital Won't Tell You
Venture Capital Cycle – How Does It Go?
Sources Of Venture Capital News
Astellas Venture Capital: Aim Big
The Advantages Of Taking Venture Capital Courses
Venture Capital Firms In New York: Chase Your Dreams
Choosing The Best Venture Capital Consultant
How And Where To Find Venture Capital Insurance
What Do Venture Capitalists Want?
Venture Capital Fund: A Viable Risk?
Venture Capital: The Basics
Kinds Of Venture Capital Firms And What They Do
Venture Capital And Its Characteristics
Venture Capital – Knowing Your Funding Options
What You Need To Apply For A Venture Capital
Making A Difference With Non-Profit Venture Capital
Kinds Of Venture Capital Jobs
Venture Capital And Grants – Is It Right For Your Business?






My Articles


Venture Capital Fund: A Viable Risk? Venture capital fund is considered one of the financing..


What Do Venture Capitalists Want? Venture capitalists come across a lot of companies that need funding..


Venture Capital And Grants – Is It Right For Your Business? You've heard of some companies which were put up through..


How And Where To Find Venture Capital Insurance Venture capital insurance is one topic which may seem..



Related Videos:

Related News:

 
Venture capital IPOs down 90 pct last year-surveys - Reuters

    

Wall Street Journal Blogs

Venture capital IPOs down 90 pct last year-surveys
Reuters - Jan 5, 2009
Two polls, one by Dow Jones VentureSource and the other by the National Venture Capital Association and Thomson Reuters, found that the number of IPOs ...
Venture capital-backed IPOs hit 30-year low in 2008 Bizjournals.com
IPOs at standstill as economy stalls Los Angeles Times
Slowdown puts start-up funds in peril Boston Globe
New York Times - San Francisco Chronicle
all 92 news articles



Flow of venture capital for green tech slows - San Francisco Chronicle

    

Flow of venture capital for green tech slows
San Francisco Chronicle,  USA - 8 hours ago
(01-06) 18:40 PST -- After years of rapid growth, venture capital investments in green technology started shrinking in the fourth quarter of 2008 as the ...
Venture Capital Investment in Greentech and Renewable Energy ... PR Newswire (press release)
Venture Capitalists Still See Green in Green xchange Magazine
Cleantech Venture Investment in ‘08 Breaks Record, Despite Weak Finish Earth2Tech
My MBA Career - Greentech Media
all 31 news articles